Microbicide safety/efficacy studies in animals: macaques and small animal models
- 1 September 2008
- journal article
- microbicides
- Published by Wolters Kluwer Health in Current Opinion in HIV and AIDS
- Vol. 3 (5) , 567-573
Abstract
Purpose of review A number of microbicide candidates have failed to prevent HIV transmission in human clinical trials, and there is uncertainty as to how many additional trials can be supported by the field. Regardless, there are far too many microbicide candidates in development, and a logical and consistent method for screening and selecting candidates for human clinical trials is desperately needed. The unique host and cell specificity of HIV, however, provides challenges for microbicide safety and efficacy screening, that can only be addressed by rigorous testing in relevant laboratory animal models. Recent findings A number of laboratory animal model systems ranging from rodents to nonhuman primates, and single versus multiple dose challenges have recently been developed to test microbicide candidates. These models have shed light on both the safety and efficacy of candidate microbicides as well as the early mechanisms involved in transmission. This article summarizes the major advantages and disadvantages of the relevant animal models for microbicide safety and efficacy testing. Summary Currently, nonhuman primates are the only relevant and effective laboratory model for screening microbicide candidates. Given the consistent failures of prior strategies, it is now clear that rigorous safety and efficacy testing in nonhuman primates should be a prerequisite for advancing additional microbicide candidates to human clinical trials.Keywords
This publication has 45 references indexed in Scilit:
- Concentrations of Dapivirine in the Rhesus Macaque and Rabbit following Once Daily Intravaginal Administration of a Gel Formulation of [ 14 C]Dapivirine for 7 DaysAntimicrobial Agents and Chemotherapy, 2008
- Antiretroviral Pre-exposure Prophylaxis Prevents Vaginal Transmission of HIV-1 in Humanized BLT MicePLOS Medicine, 2008
- Can the New Humanized Mouse Model Give HIV Research a Boost?PLOS Medicine, 2008
- Human Immunodeficiency Virus Type 1 Derivative with 7% Simian Immunodeficiency Virus Genetic Content Is Able To Establish Infections in Pig-Tailed MacaquesJournal of Virology, 2007
- A Comprehensive Murine Model to Evaluate Topical Vaginal Microbicides: Mucosal Inflammation and Susceptibility to Genital Herpes as Surrogate Markers of SafetyThe Journal of Infectious Diseases, 2007
- Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1Journal of Experimental Medicine, 2007
- Development of a Nonhuman Primate Model for Trichomonas vaginalis InfectionSexually Transmitted Diseases, 2006
- Preclinical Safety and Efficacy Assessments of Dendrimer-Based (SPL7013) Microbicide Gel Formulations in a Nonhuman Primate ModelAntimicrobial Agents and Chemotherapy, 2006
- Preclinical Evaluation of Synthetic −2 RANTES as a Candidate Vaginal Microbicide To Target CCR5Antimicrobial Agents and Chemotherapy, 2006
- Multiple Vaginal Exposures to Low Doses of R5 Simian‐Human Immunodeficiency Virus: Strategy to Study HIV Preclinical Interventions in Nonhuman PrimatesThe Journal of Infectious Diseases, 2005